HSD1590

Overview

HSD1590 is potent ROCK inhibitor, with IC 50 s of 1.22 and 0.51 nM for ROCK1 and ROCK2 , respectively. HSD1590 exhibits single digit nanomolar binding to ROCK (K d s<2 nM). HSD1590 displays low cytotoxicity.

Application

Products | Products > Disease Areas > Lung Fibrosis | Products > Disease Areas > Respiratory Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Pulmonary Disease | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > TGF-beta/Smad | Products > Signaling Pathways > Stem Cell/Wnt | Products > Signaling Pathways > Cytoskeleton | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Stem Cells | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > ROCK

Product Information

• Catalog No.: HY-126275
• CAS No.: 2379279-96-4
• Molecular Formula: C20H18BN3O3
• Molecular Weight: 359.19
• Purity: 99.00%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 6.25 mg/mL (17.40 mM); Clear solution
• Availability: In-stock

Source

Original product source